Aytu BioPharma, Inc. ( AYTU) - Key Metrics
AYTU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $1.31 | $0 | $0.36 | $0.36 |
| 2026Q3 | $1.18 | -$0.53 | -$0.40 | -$0.40 |
| 2026Q2 | $1.51 | -$1.05 | $0.37 | $0.36 |
| 2026Q1 | $1.47 | $0.21 | -$0.07 | -$0.07 |
| 2025Q4 | $2.23 | -$2.92 | $0.41 | $0.41 |
AYTU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | 2.56 |
| 2026Q3 | 0% | -1.29 |
| 2026Q2 | 0% | -0.62 |
| 2026Q1 | 0% | 2.24 |
| 2025Q4 | 0% | -0.19 |
AYTU Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 16.59% | 0% |
| 2026Q3 | -14.57% | 0% |
| 2026Q2 | 14.02% | 0% |
| 2026Q1 | -3.48% | 0% |
| 2025Q4 | 18.82% | 0% |
AYTU
Price: $1.97
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 55600
Ebitda: -9.2 millionMarket Capitalization: 22.2 million